DK661387D0 - Stabiliseret adjuvanssuspension indeholdende dimethyldioctadecylammoniumbromid - Google Patents

Stabiliseret adjuvanssuspension indeholdende dimethyldioctadecylammoniumbromid

Info

Publication number
DK661387D0
DK661387D0 DK661387A DK661387A DK661387D0 DK 661387 D0 DK661387 D0 DK 661387D0 DK 661387 A DK661387 A DK 661387A DK 661387 A DK661387 A DK 661387A DK 661387 D0 DK661387 D0 DK 661387D0
Authority
DK
Denmark
Prior art keywords
bromide
dimethyledioctadecylammonium
adjustive
stabilized
suspension containing
Prior art date
Application number
DK661387A
Other languages
English (en)
Other versions
DK661387A (da
Inventor
Lucas Alfonsus Theodor Hilgers
Marinus Wijnand Weststrate
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Publication of DK661387D0 publication Critical patent/DK661387D0/da
Publication of DK661387A publication Critical patent/DK661387A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
DK661387A 1986-12-19 1987-12-16 Stabiliseret adjuvanssuspension indeholdende dimethyldioctadecylammoniumbromid DK661387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603232 1986-12-19

Publications (2)

Publication Number Publication Date
DK661387D0 true DK661387D0 (da) 1987-12-16
DK661387A DK661387A (da) 1988-06-20

Family

ID=19849021

Family Applications (1)

Application Number Title Priority Date Filing Date
DK661387A DK661387A (da) 1986-12-19 1987-12-16 Stabiliseret adjuvanssuspension indeholdende dimethyldioctadecylammoniumbromid

Country Status (11)

Country Link
US (1) US5026546A (da)
EP (1) EP0273512B1 (da)
JP (1) JPS63165329A (da)
AT (1) ATE60999T1 (da)
DE (1) DE3768232D1 (da)
DK (1) DK661387A (da)
ES (1) ES2037072T3 (da)
GR (1) GR3001527T3 (da)
IE (1) IE60698B1 (da)
NZ (1) NZ222938A (da)
PT (1) PT86376B (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432431B1 (en) * 1989-11-16 1993-06-16 PHIDEA S.p.A. Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US6991797B2 (en) * 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US5955077A (en) * 1993-07-02 1999-09-21 Statens Seruminstitut Tuberculosis vaccine
BE1008977A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
US6982085B2 (en) * 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US20040013685A1 (en) * 1997-11-10 2004-01-22 Peter Andersen Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
FR2814957B1 (fr) * 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation
EA011578B1 (ru) * 2002-08-26 2009-04-28 Пфайзер Продактс Инк. Иммуногенная композиция для защиты крупного рогатого скота от инфекций респираторной и репродуктивной систем и ее применение
US6962608B1 (en) 2002-10-01 2005-11-08 The Regents Of The University Of California Regenerable antimicrobial polymers and fibers with oxygen bleaches
CA2513655C (en) 2003-01-21 2011-11-22 Chiron Corporation Use of tryptanthrin compounds for immune potentiation
EP1608369B1 (en) 2003-03-28 2013-06-26 Novartis Vaccines and Diagnostics, Inc. Use of organic compounds for immunopotentiation
JP2008504292A (ja) 2004-06-24 2008-02-14 ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド 免疫増強用の化合物
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
US7749520B2 (en) * 2004-07-07 2010-07-06 Statens Serum Institut Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
ITBO20050363A1 (it) 2005-05-26 2006-11-27 Maccaferri Spa Off Elemento leggero di protezione filtro del tipo a materasso
CA2646891A1 (en) * 2006-03-23 2007-09-27 Novartis Ag Immunopotentiating compounds
WO2007109810A2 (en) * 2006-03-23 2007-09-27 Novartis Ag Methods for the preparation of imidazole-containing compounds
CA2646539A1 (en) 2006-03-23 2007-09-27 Novartis Ag Imidazoquinoxaline compounds as immunomodulators
CL2008001806A1 (es) 2007-06-20 2008-09-05 Wyeth Corp Composicion de vacuna en emulsion agua en aceite que comprende un antigeno y un adyuvante en la fase acuosa; y metodo de elaboracion.
WO2009156960A2 (en) 2008-06-27 2009-12-30 Pfizer Inc. Novel adjuvant compositions
CN102272134B (zh) 2008-12-09 2013-10-16 吉里德科学公司 Toll样受体调节剂
JP6586083B2 (ja) 2013-09-19 2019-10-02 ゾエティス・サービシーズ・エルエルシー 油性アジュバント
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
KR20170097116A (ko) 2015-01-16 2017-08-25 조에티스 서비시즈 엘엘씨 구제역 백신
WO2019236469A1 (en) 2018-06-04 2019-12-12 Apros Therapeutics, Inc. Tlr7 peptide conjugates
BR112020026989A2 (pt) 2018-07-02 2021-03-30 Ayuvis Research, Inc. Novas pequenas moléculas de imunomodulação

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3919411A (en) * 1972-01-31 1975-11-11 Bayvet Corp Injectable adjuvant and compositions including such adjuvant

Also Published As

Publication number Publication date
JPS63165329A (ja) 1988-07-08
EP0273512A3 (en) 1988-07-27
DK661387A (da) 1988-06-20
EP0273512A2 (en) 1988-07-06
DE3768232D1 (de) 1991-04-04
GR3001527T3 (en) 1992-11-23
PT86376A (en) 1988-01-01
IE873407L (en) 1988-06-19
PT86376B (pt) 1990-11-20
US5026546A (en) 1991-06-25
NZ222938A (en) 1990-11-27
ES2037072T3 (es) 1993-06-16
EP0273512B1 (en) 1991-02-27
ATE60999T1 (de) 1991-03-15
IE60698B1 (en) 1994-08-10

Similar Documents

Publication Publication Date Title
DK661387A (da) Stabiliseret adjuvanssuspension indeholdende dimethyldioctadecylammoniumbromid
PT625053E (pt) Vacina a base de urease contra a infeccao por helicobacter
BR8600840A (pt) Polimerizacao catalisada por oxianion
AR246509A1 (es) Una cetimina, su preparacion y un agente de entrecruzamiento que la contiene.
FI873083A (fi) Foerfarande foer odling av bordetella pertussis, kikhostatoxoid och kikhostavaccin.
IT1116840B (it) Perfezionamento nelle composizioni farmaceutiche contenenti prostaglandina
SU575022A3 (ru) Способ получени четвертичных аммониевых солей -диэтиламинопропил- -(2 инданил) -анилина
DE3673110D1 (de) Verfahren zur herstellung von n-alkyl-substituierten hydroxylammoniumchloriden.
DK116687A (da) Farmaceutisk praeparat indeholdende aenovantroneae
ES515094A0 (es) Procedimiento para preparar derivados fluorados de diaminohepteno o -heptina.
AU1491583A (en) Optically active imidazolylpropanols
ES2062044T3 (es) Un procedimiento para preparar un derivado de 2-oxoimidazolidina opticamente activo.
ATE61372T1 (de) Thionophosphonsaeureester.
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.
GB1171619A (en) Vaccine adjuvants
BR7600561A (pt) Processo de preparar um agente anidro de estampagem profunda

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment